Search clinical trials for: Vaccination against SARS-CoV-2

Total 1088 results

Insel Gruppe AG, University Hospital Bern
University Hospital Freiburg

Recruiting

Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion (VANCO)

Surgical Site Infection

Switzerland
Indiana University

Completed

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers (COVID-Antibody)

SARS-CoV-2

United States
Mallinckrodt

Completed

A Study of Fibrocaps™ in Surgical Bleeding (FINISH-3)

Mild or Moderate Surgical Bleeding

United States, Netherlands, United Kingdom, Belgium
Sheba Medical Center

Completed

COVID-19 Vaccine and Ovarian Reserve

Vaccine Adverse Reaction | Fertility Issues

Israel
University Hospital, Lille

Active, not recruiting

Covid-19 Vaccine Response in Elderly Subjects (MONITOCOVAGING)

Covid19 Vaccine

France
Maastricht University Medical Center
Top Institute Food and Nutrition

Completed

Oro-gastro-intestinal Digestion of Emulsified Fat

Obesity

Netherlands
IRCCS San Raffaele

Recruiting

Determination of COVID-19 Related Virus in Central Nervous System

CNS Infection | CNS Disease | COVID-19 Testing

Italy
Dr. Soetomo General Hospital
Indonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia

Recruiting

UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

COVID-19 Pandemic | COVID-19 Vaccines

Indonesia
Novavax

Completed

A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) (COVID-19)

SARS-CoV-2 Infection

South Africa
University of Nottingham

Completed

Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot (RB-TPP)

Covid19

United Kingdom
Boehringer Ingelheim

Completed

COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR

Covid-19

Mexico
National Institute of Allergy and Infectious Diseases...

Withdrawn

SARS Coronavirus Vaccine (SARS-CoV)

Coronavirus (SARS-CoV)

United States
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
University of Maryland, Baltimore

Completed

COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2

COVID-19 | SARS-CoV2 Infection

United States
Administracion Nacional de Laboratorios e Institutos...

Recruiting

Safety and Effectiveness of an Immunobiological Drug in CoViD-19 (INPB001)

Covid19 | COVID-19 Pneumonia | COVID-19 Respiratory Infection

Argentina
Women and Infants Hospital of Rhode Island

Recruiting

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

Postoperative Complications

United States
Cinnagen
Shahid Beheshti University of Medical Sciences; Vaxine Pty Ltd

Completed

Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

COVID-19

Iran, Islamic Republic of
Bayer
CureVac

Withdrawn

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (CV-NCOV-011)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
University of Alabama at Birmingham
ViraCor Laboratories

Withdrawn

COVID Vaccine Immunity in Kidney Transplant Recipients

End Stage Renal Disease | Kidney Transplant; Complications
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

COVID-19

Iran, Islamic Republic of
Centre Oscar Lambret
National Cancer Institute, France; Pierre Fabre Laboratories

Completed

Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma (OVIMA-1210)

Low-Grade Glioma

France
University Hospital, Strasbourg, France

Recruiting

Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients (COVATRHUS)

Kidney Transplant Recipients

France
Providence Health & Services

Terminated

Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication

Multiple Sclerosis

United States
Baskent University
Hikmet Eda Aliskan; Hatice Hale Gumus; Ilker Odemis; Zuhal Ekici Unsal

Completed

SARS Cov_2 Incidence of Healthy Health Workers

SARS COV-2 IgG Levels on Health Workers

Turkey
Tata Main Hospital

Completed

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

Covid19

India
University of Arizona

Completed

Immune Response to the COVID-19 Vaccine

Cancer | Covid19 | Malignancy | Vaccine Response Impaired

United States
ANRS, Emerging Infectious Diseases
LinKinVax; Vaccine Research Institute (VRI), France

Recruiting

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

COVID-19

France
Windsor-Essex Compassionate Care Community
Cairo University

Recruiting

The Effect of Intrawound Vancomycin Powder in Spine Surgery

Spine Disease

Egypt, Canada
William Beaumont Hospitals

Completed

Screening to Prophylax Against Clostridium Difficile Infection - (StoP CDI)

Clostridium Difficile Infection

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC; Parker Institute for Cancer Immunotherapy

Active, not recruiting

Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

Advanced Sarcoma

United States
Cinnagen
Vaxine Pty Ltd

Completed

Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Covid19

Iran, Islamic Republic of
Sinocelltech Ltd.

Recruiting

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Covid19

United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru
Johannes Gutenberg University Mainz
Pierre Fabre Pharma GmbH

Completed

Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer (VinoMetro)

Metastatic Breast Cancer

Germany
Hospital San Jose Tec de Monterrey
Inosan Biopharma

Completed

Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19

COVID-19

Mexico
Johns Hopkins Bloomberg School of Public Health
Aminu Kano Teaching Hospital; Postgraduate Institute of Medical Education and...

Completed

Missed Opportunities for Vaccine Equity (MOVE)

Under-vaccinated

Nigeria, India
Dr. Soetomo General Hospital
Indonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia

Recruiting

UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)

COVID-19 Pandemic | COVID-19 Vaccines

Indonesia
Pontificia Universidad Catolica de Chile
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile (CoronaVarCL)

COVID-19 | Vaccines

Chile
AbbVie
Genentech, Inc.

Active, not recruiting

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Acute Myeloid Leukemia (AML)

China
Cinnagen
Vaxine Pty Ltd

Completed

Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Covid19

Iran, Islamic Republic of
Dragonfly Research, LLC

Completed

Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab (OCR-VAX)

Pathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Autoimmune Diseases

United States
Gamaleya Research Institute of Epidemiology and...
Russian Direct Investment Fund

Active, not recruiting

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

COVID-19 Prevention

Russian Federation
University Hospital, Lille

Completed

Association Between BMI and COVID-19 (BMI-SARS-CoV-2)

SARS-CoV 2

France
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 (MVA-SARS2-ST)

Covid19

Germany
Vinbiocare Biotechnology Joint Stock Company
Arcturus Therapeutics, Inc.

Completed

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) (ARCT-154-01)

COVID-19 Vaccines

Vietnam
Poitiers University Hospital

Completed

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution (BIOMARK-COVID)

Covid19

France
Université de Reims Champagne-Ardenne

Completed

SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes (SERUR)

Covid19

France
Plexision

Recruiting

Immunity After COVID-19 Vaccination

Immunity to COVID-19

United States
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

SARS-CoV-2 Infection

Mexico
Central Hospital, Nancy, France

Recruiting

Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction (CovUrinePTD)

SARS-CoV2 Infection | Proximal Tubule Dysfunction

France

Search clinical trials for: Vaccination against SARS-CoV-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations